|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 168.09 USD | -1.96% |
|
-4.99% | +11.42% |
| 07-08 | Leerink Partners Adjusts PT on Quest Diagnostics to $192 From $189, Maintains Outperform Rating | MT |
| 06-30 | Quest Diagnostics Incorporated(NYSE:DGX) dropped from Russell 1000 Dynamic Index | CI |
| Capitalization | 18.76B 16.05B 14.95B 13.9B 25.69B 1,610B 28.55B 179B 68.47B 754B 70.38B 68.93B 2,765B | P/E ratio 2025 * |
19.7x | P/E ratio 2026 * | 17.9x |
|---|---|---|---|---|---|
| Enterprise value | 24.27B 20.76B 19.33B 17.98B 33.23B 2,083B 36.93B 232B 88.58B 975B 91.04B 89.16B 3,577B | EV / Sales 2025 * |
2.25x | EV / Sales 2026 * | 2.13x |
| Free-Float |
67.83% | Yield 2025 * |
1.8% | Yield 2026 * | 1.86% |
More valuation ratios
* Estimated data
More news
Last Transcript: Quest Diagnostics Incorporated
More recommendations
More press releases
More news
| 1 day | -1.96% | ||
| 1 week | -4.99% | ||
| Current month | -6.42% | ||
| 1 month | -6.73% | ||
| 3 months | +2.50% | ||
| 6 months | +9.14% | ||
| Current year | +11.42% |
| 1 week | 167.14 |  | 174.48 |
| 1 month | 167.14 | | 182.38 |
| Current year | 148.7 | | 182.38 |
| 1 year | 137.71 | | 182.38 |
| 3 years | 119.59 | | 182.38 |
| 5 years | 104.1 | | 182.38 |
| 10 years | 59.66 | | 182.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 62 | 2022-02-02 |
Sam Samad
DFI | Director of Finance/CFO | 55 | 2022-07-10 |
Kristin Wallace
CMP | Compliance Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Pfeiffer
BRD | Director/Board Member | 75 | 2004-11-30 |
Timothy Ring
BRD | Director/Board Member | 67 | 2011-12-06 |
James Davis
CHM | Chairman | 62 | 2023-03-31 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 14.84% | 378 M€ | -7.52% | - | |
| 2.17% | 3 M€ | -.--% | - | |
| 2.05% | 6 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.96% | -4.99% | +16.64% | +26.30% | 18.76B | ||
| -0.59% | -0.14% | +15.96% | +122.12% | 90.47B | ||
| -1.28% | -3.93% | +9.80% | -30.68% | 81.95B | ||
| -0.66% | -1.27% | +42.90% | +53.07% | 27.63B | ||
| -0.60% | -2.08% | -6.00% | +35.77% | 24.73B | ||
| -1.58% | -4.69% | +21.07% | +3.88% | 20.89B | ||
| +1.20% | +2.48% | +30.78% | +226.31% | 16.32B | ||
| -1.45% | -3.16% | +25.64% | +0.06% | 15.87B | ||
| -2.56% | -6.02% | +35.50% | +231.31% | 13.82B | ||
| -1.51% | -4.67% | +15.07% | +18.09% | 13.18B | ||
| Average | -1.10% | -2.79% | +20.73% | +68.62% | 32.36B | |
| Weighted average by Cap. | -0.99% | -2.33% | +17.41% | +57.44% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.79B 9.23B 8.6B 8B 14.78B 926B 16.42B 103B 39.39B 434B 40.48B 39.65B 1,591B | 11.23B 9.61B 8.95B 8.32B 15.38B 964B 17.09B 107B 40.99B 451B 42.13B 41.26B 1,655B |
| Net income | 973M 832M 775M 721M 1.33B 83.53B 1.48B 9.29B 3.55B 39.11B 3.65B 3.58B 143B | 1.07B 915M 852M 793M 1.46B 91.81B 1.63B 10.21B 3.9B 42.99B 4.01B 3.93B 158B |
| Net Debt | 5.51B 4.71B 4.39B 4.08B 7.54B 473B 8.38B 52.58B 20.1B 221B 20.66B 20.24B 812B | 5.12B 4.38B 4.08B 3.79B 7.01B 439B 7.79B 48.87B 18.68B 206B 19.2B 18.81B 755B |
More financial data
* Estimated data
Employees
50,500
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 168.09 $ | -1.96% | 1,335,610 |
| 25-07-10 | 171.45 $ | -1.25% | 914,082 |
| 25-07-09 | 173.62 $ | +0.65% | 871,070 |
| 25-07-08 | 172.50 $ | -0.84% | 1,080,477 |
Delayed Quote Nyse, July 11, 2025 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
168.09USD
Average target price
184.10USD
Spread / Average Target
+9.52%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DGX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition